
Regulatory19 Apr 2026, 03:00 pm
MPS Pharmaa (formerly Advik Labs) not a 'Large Corporate' as per SEBI
AI Summary
MPS Pharmaa Limited, formerly Advik Laboratories Limited, has confirmed that it does not meet the criteria to be classified as a "Large Corporate" (LC) as of March 31, 2026. This declaration is made in accordance with SEBI Circular No. SEBI/HO/DDHS/P/CIR/2021/613 dated August 10, 2021, read with SEBI/HO/DDHS/DDHS-RACPOD1/P/CIR/2023/172 dated October 19, 2023, and SEBI/HO/DDHS CIR/P/2018/144 dated November 26, 2018. Consequently, the company is not subject to the specific disclosure and compliance requirements for Large Corporates concerning fund-raising through the issuance of debt securities.
Key Highlights
- Company confirms non-applicability as a 'Large Corporate' (LC).
- Not subject to SEBI's LC framework for debt securities issuance.
- Compliance based on SEBI Circulars from 2018, 2021, and 2023.
- Status confirmed as of March 31, 2026.
Price Impact
More from ADVIKLA
More in Regulatory